- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/14 - Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms
Patent holdings for IPC class C07D 239/14
Total number of patents in this class: 40
10-year publication summary
|
6
|
5
|
4
|
3
|
5
|
4
|
2
|
2
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3738 |
5 |
| The Regents of the University of California | 20842 |
3 |
| Saint Louis University | 292 |
3 |
| Sanofi | 4322 |
3 |
| Nippon Shinyaku Co., Ltd. | 325 |
2 |
| Shionogi & Co., Ltd. | 884 |
2 |
| Shanghai ChemPartner Co., Ltd. | 3 |
2 |
| Inspirna, Inc. | 32 |
2 |
| Bristol-myers Squibb Company | 4764 |
1 |
| Hoffmann-La Roche Inc. | 3825 |
1 |
| Merck Sharp & Dohme Corp. | 2184 |
1 |
| Wisconsin Alumni Research Foundation | 3903 |
1 |
| Araxes Pharma LLC | 90 |
1 |
| Arrowhead Pharmaceuticals, Inc. | 354 |
1 |
| BioCryst Pharmaceuticals, Inc. | 185 |
1 |
| Constellation Pharmaceuticals, Inc. | 219 |
1 |
| Cystic Fibrosis Foundation Therapeutics, Inc. | 8 |
1 |
| Rohm and Haas Electronic Materials Korea Ltd. | 332 |
1 |
| Eisai R&D Management Co., Ltd. | 1164 |
1 |
| Cv6 Therapeutics (NI) Limited | 33 |
1 |
| Other owners | 6 |